Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132755) titled 'Preliminary study on CD8+ T lymphocyte-driven early antifungal treatment strategies in septic patients with concomitant fungal infection' on Sept. 18.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Guangxi Zhuang Autonomous Region People's Hospital
Condition:
Non-neutropenic septic patients
Intervention:
Control group :Antifungal therapy was initiated after confirmation of fungal infection or continued until fungal infection was ruled out. Alternatively, depending on the context (e.g., study protocol or clinical practice description), here are a few more nuanced ve...